A combination of two virus-fighting drugs has proved considerably more effective against chronic hepatitis C infections than the standard single medicine
The virus causes 8,000 to 10,000 deaths per year in the United States was still undetectable in half of the combination patients , compared with just 5 percent in the interferon group is the leading cause of chronic liver disease and the No. 1 reason for liver transplants
China has started to put into mass production a genetic engineering drug which can effectively treat liver diseases has put onto the market five genetic engineering drugs , and another dozen such drugs are under research
only 15 percent to 20 percent of patients who get interferon are rid of all signs of the virus
The treatment consists of a six-month course of interferon injections and ribavirin capsules was approved by the Food and Drug Administration , a combination therapy that paired interferon with the antiviral drug ribavirin is generally not recommended for those without signs of liver damage may find themselves caught in a controversy similar to the ones that have erupted over high-priced treatments for AIDS
Some people taking a host of drugs to treat HIV can get hepatitis C _ even you have hepatitis C , and want as much flexibility as possible in picking medications
Mrs. Buchanan enrolled in a study that provided six months of treatment with Schering-Plough 's version of the drug interferon , which eliminates the virus in 10 to 20 percent of patients wanted to try the combination treatment
